Page last updated: 2024-08-24

telmisartan and Encapsulating Peritoneal Sclerosis

telmisartan has been researched along with Encapsulating Peritoneal Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, D; Li, L; Su, X; Wang, Y; Yang, X; Yu, R; Zhou, G	1

Other Studies

1 other study(ies) available for telmisartan and Encapsulating Peritoneal Sclerosis

Article	Year
Telmisartan attenuates peritoneal fibrosis via peroxisome proliferator-activated receptor-γ activation in rats. Clinical and experimental pharmacology & physiology, 2015, Volume: 42, Issue:6 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cells, Cultured; Dose-Response Relationship, Drug; Male; Peritoneal Fibrosis; PPAR gamma; Rats; Rats, Sprague-Dawley; Telmisartan	2015

Article

Year

Telmisartan attenuates peritoneal fibrosis via peroxisome proliferator-activated receptor-γ activation in rats.

Clinical and experimental pharmacology & physiology, 2015, Volume: 42, Issue:6

Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cells, Cultured; Dose-Response Relationship, Drug; Male; Peritoneal Fibrosis; PPAR gamma; Rats; Rats, Sprague-Dawley; Telmisartan

2015